517 related articles for article (PubMed ID: 26585971)
21. An increased proportion of circulating Th22 and Tc22 cells in psoriasis.
Luan L; Ding Y; Han S; Zhang Z; Liu X
Cell Immunol; 2014 Aug; 290(2):196-200. PubMed ID: 25046360
[TBL] [Abstract][Full Text] [Related]
22. Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
Piccinni MP; Lombardelli L; Logiodice F; Kullolli O; Maggi E; Barkley MS
Front Immunol; 2019; 10():642. PubMed ID: 31001262
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
Wu HQ; Zhao JJ; Li HW; Zhang Z
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
[No Abstract] [Full Text] [Related]
24. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia.
Hu Y; Li H; Zhang L; Shan B; Xu X; Li H; Liu X; Xu S; Yu S; Ma D; Peng J; Hou M
Hum Immunol; 2012 Jun; 73(6):629-35. PubMed ID: 22537755
[TBL] [Abstract][Full Text] [Related]
25. Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome.
Zhang L; Wang T; Wang XQ; Du RZ; Zhang KN; Liu XG; Ma DX; Yu S; Su GH; Li ZH; Guan YQ; Du NL
PLoS One; 2013; 8(12):e71466. PubMed ID: 24312440
[TBL] [Abstract][Full Text] [Related]
26. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
27. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
[TBL] [Abstract][Full Text] [Related]
28. Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β.
Rolla S; Bardina V; De Mercanti S; Quaglino P; De Palma R; Gned D; Brusa D; Durelli L; Novelli F; Clerico M
J Leukoc Biol; 2014 Dec; 96(6):1155-64. PubMed ID: 25097195
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis.
Tang SC; Fan XH; Pan QM; Sun QS; Liu Y
J Neurol Sci; 2015 Jan; 348(1-2):174-80. PubMed ID: 25498842
[TBL] [Abstract][Full Text] [Related]
30. Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.
Du HZ; Wang Q; Ji J; Shen BM; Wei SC; Liu LJ; Ding J; Ma DX; Wang W; Peng J; Hou M
J Clin Immunol; 2013 Feb; 33(2):436-45. PubMed ID: 23054344
[TBL] [Abstract][Full Text] [Related]
31. The Imbalance between Foxp3
Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
[TBL] [Abstract][Full Text] [Related]
32. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
33. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
34. Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses.
Kanayama K; Nakamura K; Ogino H; Sumida Y; Ihara E; Akiho H; Takayanagi R
Dig Dis Sci; 2011 Dec; 56(12):3525-33. PubMed ID: 21678051
[TBL] [Abstract][Full Text] [Related]
35. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
36. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
37. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.
Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J
Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020
[TBL] [Abstract][Full Text] [Related]
38. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
[TBL] [Abstract][Full Text] [Related]
39. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis.
Fu D; Song X; Hu H; Sun M; Li Z; Tian Z
Mol Med Rep; 2016 Jun; 13(6):4606-12. PubMed ID: 27082311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
